| GS | gallstone; Gardner syndrome; gastric shield; general surgery; gestational score; Gilbert syndrome; g... |
|---|---|
| GT | gait training; galactosyl transferase; gastrostomy; generation time; genetic therapy; gingiva treatm... |
| MN | a blood group in the MNSs blood group system; malignant nephrosclerosis; Master of Nursing; meganewt... |
| AIIS | Anterior Inferior Iliac Spine |
| ASIS | Anterior Superior Iliac Spine |
methyl group
Q blood group system
| trochlear spine | A spicule of bone arising from the edge of the trochlear fovea, giving attachment to the pulley of the superior oblique muscle of the eyeball. Synonym: spina trochlearis. (05 Mar 2000) |
|---|---|
| unstable cervical spine fractures | <radiology> Flexion: bilateral interfacetal dislocation, flexion teardrop fracture (usually C5 or C6) extension: extension teardrop fracture (usually C2 or C3), hangman's fracture, extension-dislocation, extension-fracture-dislocation, odontoid fracture vertical compression: Jefferson burst fracture see: cervical spine fractures (12 Dec 1998) |
| lesser tympanic spine | The posterior edge of the tympanic notch (of Rivinus). Synonym: spina tympanica minor. (05 Mar 2000) |
| acromial end of clavicle | The flattened lateral end of the clavicle that articulates with the acromion and is anchored to the coracoid process by the conoid and trapezoid ligaments. Synonym: extremitas acromialis claviculae, acromial end of clavicle. (05 Mar 2000) |
| blunt-end | Refers to double-stranded DNA in which there are no unpaired bases at the end. (05 Mar 2000) |
| blunt-end DNA | <molecular biology> A fragment of a DNA molecule in which the ends of both strands are even with each other rather than one strand being longer than the other. (09 Oct 1997) |
| blunt-end ligation | A lab technique to join together two pieces of blunt-end DNA, such as an insert into a cloning vector, which requires the enzyme ligase because there are no single-stranded overhanging ends for the attachment to form more spontaneously, by itself. (09 Oct 1997) |
| by-end | Private end or interest; secret purpose; selfish advantage. Alternative forms: bye-end. (20 Mar 1998) |
| capped 5'-end | A methylated (has a -CH3 attached) guanosine nucleotide attached to the 5'-end (the beginning) of an eukaryotic mRNA, thought to give the mRNA stability. (09 Oct 1997) |
| glycosylation end products, advanced | Products derived from the nonenzymatic reaction of glucose and proteins in vivo that exhibit a yellow-brown pigmentation and an ability to participate in protein-protein cross-linking. These substances are involved in biological processes relating to protein turnover and it is believed that their excessive accumulation contributes to the chronic complications of diabetes mellitus. (12 Dec 1998) |
| root end cyst | An inflammatory odontogenic cyst derived histogenetically from Malassez' epithelial rests surrounding the root apex of a nonvital tooth. Synonym: periapical cyst, radicular cyst, root end cyst. (05 Mar 2000) |
| root end granuloma | Chronic nonsuppurative inflammation of periapical tissue resulting from irritation following pulp disease or endodontic treatment. (12 Dec 1998) |
| miniature end plate potential | <physiology> Small fluctuations (typically 0.5 mV) in the resting potential of postsynaptic cells. They are the same shape as, but much smaller than, the end plate potentials caused by stimulation of the presynaptic cell. Miniature end plate potentials are considered as evidence for the quantal release of neurotransmitters at chemical synapses, a single miniature end plate potential resulting from the release of the contents of a single synaptic vesicle. (12 Jan 1998) |
| positive end-expiratory pressure | A technique used in respiratory therapy in which airway pressure greater than atmospheric pressure is achieved at the end of exhalation by introduction of a mechanical impedance to exhalation. (05 Mar 2000) |
| skin test end-point titration | A quantitative form of intradermal testing for the relative allergenicity of a substance. It is used to determine the amount of an allergen that will be tolerated in immunotherapy. (12 Dec 1998) |